Enochian Biosciences Inc. (ENOB)
Enochian Biosciences Statistics
Share Statistics
Enochian Biosciences has 63.7M shares outstanding. The number of shares has increased by 0% in one year.
| 63.7M |
| 0% |
| 0% |
| n/a |
| n/a |
| 18,870 |
| 7.41% |
Short Selling Information
| n/a |
| n/a |
| n/a |
| n/a |
Valuation Ratios
The PE ratio is -1.86 and the forward PE ratio is null. Enochian Biosciences's PEG ratio is -0.1.
| -1.86 |
| n/a |
| 0 |
| n/a |
| 1.14 |
| -13.6 |
| -0.1 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Enochian Biosciences.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 0.07, with a Debt / Equity ratio of 0.03.
| 0.07 |
| 0.07 |
| 0.03 |
| -0.05 |
| -0.34 |
| -80.73 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| n/a |
| $-3,665,916.86 |
| 22 |
| 0 |
| n/a |
Taxes
| n/a |
| 0% |
Stock Price Statistics
The stock price has increased by -72.69% in the last 52 weeks. The beta is 0.94, so Enochian Biosciences's price volatility has been higher than the market average.
| 0.94 |
| -72.69% |
| 0.97 |
| 1.11 |
| 77.82 |
| 254,603 |
Balance Sheet
The company has 220.47K in cash and 3.79M in debt, giving a net cash position of -3.57M.
| 220.47K |
| 3.79M |
| -3.57M |
| -324.68M |
| 58,018.1B |
| -11,355.2B |
Cash Flow
In the last 12 months, operating cash flow was -10.97M and capital expenditures -70.43K, giving a free cash flow of -11.04M.
| -10.97M |
| -70.43K |
| -11.04M |
| -0.11 |
Margins
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Dividends & Yields
ENOB does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| -8.75 |
| 1 |